{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T11:27:22Z","timestamp":1785583642898,"version":"3.56.0"},"reference-count":14,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>Auditory abnormal sensations encompass various subjective auditory symptoms such as tinnitus, hyperacusis, aural fullness, autophony, dysacusis, pseudo-hallucinations, and misophonia. Although tinnitus management typically includes lifestyle counseling and sound therapy, there remains no established treatment for symptoms like aural fullness or pseudo-hallucinations with unknown etiology. In cases where central sensory processing abnormalities or emotional instability are suspected, psychotropic medications may offer benefit. We report two cases in which aripiprazole, an atypical antipsychotic, was effective in treating such symptoms. In both cases, traditional approaches such as antidepressants and supportive therapy were insufficient, but aripiprazole led to marked improvement in subjective auditory symptoms. These cases suggest a potential role for pharmacological modulation of central sensory and emotional regulation in patients with auditory abnormal sensations. One involved a man with phonophobia and aural fullness, and the other a woman with tinnitus and pseudo-hallucinations.<\/jats:p>","DOI":"10.3389\/fpsyt.2025.1614500","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T13:12:53Z","timestamp":1748956373000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: Potential of pharmacological treatment for auditory abnormal sensations with aripiprazole: a report of two cases"],"prefix":"10.3389","volume":"16","author":[{"given":"Fumiyuki","family":"Goto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Kaneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Okami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Wasano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"key":"B1","unstructured":"Baguley\n              DM\n            \n            \n              Andersson\n              G\n            \n          \n          10.1016\/S0079-6123(07)66015-4\n          Plural Publishing\n          Hyperacusis: mechanisms, diagnosis, and therapies\n          \n          2007"},{"key":"B2","doi-asserted-by":"crossref","unstructured":"Jastreboff\n              PJHJ\n            \n          \n          10.1017\/CBO9780511544989\n          Cambridge University Press\n          Tinnitus retraining therapy: implementing the neurophysiological model\n          \n          2004","DOI":"10.1017\/CBO9780511544989"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.heares.2016.05.009","article-title":"A systematic review of the reporting of tinnitus prevalence and severity","volume":"337","author":"McCormack","year":"2016","journal-title":"Hear Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1044\/2014_AJA-14-0010","article-title":"A review of hyperacusis and future directions: part I. Definitions and manifestations","volume":"23","author":"Tyler","year":"2014","journal-title":"Am J Audiol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0030-6665(02)00160-3","article-title":"Classification and epidemiology of tinnitus","volume":"36","author":"Heller","year":"2003","journal-title":"Otolaryngol Clin North Am"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2010.04.029","article-title":"The neural correlates of tinnitus-related distress","volume":"52","author":"Vanneste","year":"2010","journal-title":"Neuroimage"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1018466108","article-title":"Phantom percepts: tinnitus and pain as persisting aversive memory networks","volume":"108","author":"De Ridder","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B8","doi-asserted-by":"publisher","first-page":"100657","DOI":"10.1016\/j.xocr.2025.100657","article-title":"A case of refractory dizziness effectively treated with the addition of aripiprazole to antidepressant therapy","volume":"34","author":"Goto","year":"2025","journal-title":"Otolarynglogy Case Rep"},{"key":"B9","doi-asserted-by":"publisher","first-page":"100664","DOI":"10.1016\/j.xocr.2025.100664","article-title":"Brexpiprazole augmentation in antidepressant therapy for persistent postural-perceptual dizziness (PPPD): A case report","volume":"35","author":"Goto","year":"2025","journal-title":"Otolarynglogy Case Rep"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/acr.v63.11s","article-title":"Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP)","author":"Hawker","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v62n1201","article-title":"Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 2: illustrating their mechanism of action","volume":"62","author":"Stahl","year":"1","journal-title":"J Clin Psychiatry 200"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2013.06.002","article-title":"Solifenacin-induced delirium and hallucinations","volume":"35","author":"Stuhec","year":"2013","journal-title":"Gen Hosp Psychiatry"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2013.10.016","article-title":"Trimethoprim-sulfamethoxazole-related hallucinations","volume":"36","author":"Stuhec","year":"2014","journal-title":"Gen Hosp Psychiatry"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2025.1614500\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T13:12:55Z","timestamp":1748956375000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2025.1614500\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":14,"alternative-id":["10.3389\/fpsyt.2025.1614500"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2025.1614500","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,3]]},"article-number":"1614500"}}